HBOT and Stem Cell Therapy in Autism

I DO NOT USE HBOT AND DO NOT RECOMMEND STEM CELL THERAPY. THE REASONS ARE BELOW:

HBOT:

It delivers 100% oxygen at pressures exceeding atmospheric pressure, thereby dramatically increasing the amount of dissolved oxygen in blood and tissues. This hyperoxic environment enhances oxygen metabolism but also increases the generation of ROS such as:

Superoxide anion (O₂⁻)

Hydrogen peroxide (H₂O₂)

Hydroxyl radicals (•OH)

Excessive or prolonged HBOT may lead to:

• Oxidative damage to lipids, proteins, and DNA

• Neurotoxicity or pulmonary toxicity, especially at higher pressures or long durations

STEM CELL THERAPY IN AUTISM:

Immune Reactions and Inflammation

Graft-versus-host disease (GVHD) in allogeneic stem cell use (from donor sources).

Risk of autoimmunity activation in children already prone to immune dysregulation.

Infections

Introduction of stem cells, especially if not properly screened or processed, can carry infection risks (bacterial, viral, fungal).

Intrathecal injections carry additional risks of meningitis or CNS infections.

Tumor Formation

Though rare, unregulated stem cells may cause tumorigenesis (e.g., teratomas), particularly with embryonic or pluripotent cell types.

They might differentiate into undesired cell types, especially in poorly regulated procedures.

Neurological Side Effects

Some children experience headaches, seizures, increased irritability, or regression after stem cell infusions—particularly after intrathecal administration.

Reported side effects include fever, nausea, vomiting, pain, and fatigue.

Lack of Standardized Protocols

Lack of regulatory oversight in many countries (including parts of Eastern Europe, Latin America, and Asia).

Wide variation in:

–         Stem cell sources (umbilical cord, bone marrow, adipose, fetal, etc.)

–         Cell counts and quality

–         Dosing and delivery route

This makes it hard to assess safety or efficacy and increases the risk of complications.

Dr. Ken Alibek,

MD, PhD, ScD